Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

New bromodomain-containing protein inhibitors discovered by ConverGene, NIH

Nov. 18, 2020

Rutgers describes new zinc complexes

Nov. 18, 2020

Mirati Therapeutics identifies new polycomb protein EED inhibitors

Nov. 18, 2020

New mutant EGFR inhibitors described by Bayer, The Broad Institute, Dana-Farber Cancer Institute

Nov. 18, 2020

Novel series of triaryl compounds acting as 20S proteasome inhibitors with subunit selectivity

Nov. 18, 2020

2,4-Diamino-6-methylpyrimidines as novel histone lysine methyltransferase G9a/GLP inhibitors

Nov. 18, 2020

FDA clears initiation of phase II trials of NBTXR-3 in HNSCC

Nov. 17, 2020

Ependymomas may respond to PARP inhibitors

Nov. 17, 2020

Osaka University presents new histone demethylase inhibitors

Nov. 17, 2020

Linking two liver cancer culprits

Nov. 17, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...